Takeda Pharmaceutical annual total assets
2018
2019
2020
2021
2022
2023
2024
2025
2026
Takeda Pharmaceutical Total Assets Growth & History (TAK)
Takeda Pharmaceutical's total assets was ¥15.51T for fiscal 2026.
View full Takeda Pharmaceutical company overviewTakeda Pharmaceutical annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | ¥15.51T | ¥1.26T | +8.87% |
| 2025 | 2025-03-31 | ¥14.25T | −¥860.45B | −5.70% |
| 2024 | 2024-03-31 | ¥15.11T | ¥1.15T | +8.25% |
| 2023 | 2023-03-31 | ¥13.96T | ¥779.73B | +5.92% |
| 2022 | 2022-03-31 | ¥13.18T | ¥265.73B | +2.06% |
| 2021 | 2021-03-31 | ¥12.91T | ¥91.20B | +0.71% |
| 2020 | 2020-03-31 | ¥12.82T | −¥971.68B | −7.04% |
| 2019 | 2019-03-31 | ¥13.79T | ¥9.69T | +235.88% |
| 2018 | 2018-03-31 | ¥4.11T | — | — |
Takeda Pharmaceutical quarterly total assets
Q4.18
Q4.19
Q4.20
Q4.21
Q4.22
Q4.23
Q4.24
Q4.25
Q1.26
Q2.26
Q3.26
Q4.26
Q1.27
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-06-30 | ¥15.66T | ¥1.66T | +11.84% |
| Q4 2026 | 2026-03-31 | ¥15.51T | ¥1.26T | +8.87% |
| Q3 2026 | 2025-12-31 | ¥15.41T | — | — |
| Q2 2026 | 2025-09-30 | ¥14.47T | — | — |
| Q1 2026 | 2025-06-30 | ¥14.00T | — | — |
| Q4 2025 | 2025-03-31 | ¥14.25T | −¥860.45B | −5.70% |
| Q4 2024 | 2024-03-31 | ¥15.11T | ¥1.15T | +8.25% |
| Q4 2023 | 2023-03-31 | ¥13.96T | ¥779.73B | +5.92% |
| Q4 2022 | 2022-03-31 | ¥13.18T | ¥265.73B | +2.06% |
| Q4 2021 | 2021-03-31 | ¥12.91T | ¥91.20B | +0.71% |
| Q4 2020 | 2020-03-31 | ¥12.82T | −¥971.68B | −7.04% |
| Q4 2019 | 2019-03-31 | ¥13.79T | ¥9.69T | +235.88% |
| Q4 2018 | 2018-03-31 | ¥4.11T | — | — |
Takeda Pharmaceutical total assets trends
Over the last five fiscal years, Takeda Pharmaceutical's total assets increased from ¥12.91T to ¥15.51T, a change of ¥2.60T. The latest reported quarter, Q1 2027, shows ¥15.66T.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Takeda Pharmaceutical source filings ↗